Cancer Progress

Lumanity (formerly Cello BioConsulting/Defined Health). Oncology thought leadership: Jeff Bockman, PhD, Mike Rice, MBA, and Viraj Parekh, PhD

[Jay Newt @Jeffnew1906]

@JamesMartinSJ Meanwhile, what class and honor looks like:

[James Martin, SJ @JamesMartinSJ]

God help us. This is disgraceful language coming from a Christian, or anyone with a soul. It was just as wrong to celebrate the death of Charlie Kirk as it is to celebrate that of Robert Mueller. May they rest in peace. And may we never forget that Jesus's message is about mercy.

[CNN @CNN]

The United States has fallen to its worst-ever position in a leading global index that measures views of corruption in the public sector among independent experts and businesspeople. https://t.co/YtEVTQp6IQ

[Jacob Plieth @JacobPlieth]

Key late-breakers at Asco #GU26 include Litespark-011 & 022, Keynote-B15... and who's heard of Flare Therapeutics? Via @ApexOnco -> https://t.co/bXcANMQu5m $MRK $PFE $ALMPF $CGON $VIR

[Nature Reviews Drug Discovery @NatRevDrugDisc]

This article in the February issue analyses M&As and partnerships in the biopharma industry in 2025, with GSK's potential $12.5 billion partnership with Hengrui Pharmaceuticals focused on a PDE3/4 inhibitor for COPD in the top spot for licensing deals https://t.co/XNvCW57QmG

[Cancer Progress @CancerProgress]

An optimistic view of IO 2.0 future at #IO360Summit by #AxelHooos: complex multifunctional engineering of biologics, even beyond bispecifics. #immunooncology #immunotherapy #oncology #cancer

[Wei Zhao @zhaoweiasu]

4️⃣ First prime editing in the animal brain (AHC)
Correcting ATP1A3/Atp1a3 mutations reverses neurological features in mice, proof that programmable gene editing can treat CNS diseases.

David Liu lab collaborated with @jacksonlab and @RAREH0pe

https://t.co/L3U5ASuy3v

[Cancer Progress @CancerProgress]

@BiotechTV @Enara_Bio Listening to their talk now!

[Cancer Progress @CancerProgress]

@BiotechTV @sitcancer @MyOncology @MarengoTx Great choice for kicking off with Zhen!

[Cancer Progress @CancerProgress]

@BiotechTV @sitcancer @ArtKrieg Go, Art!

[Cancer Progress @CancerProgress]

https://t.co/QYL9aViqRC

[Cancer Progress @CancerProgress]

Great awards morning at the 40th Society for Immunotherapy of Cancer. #Immunotherapy #cancer

[Cancer Progress @CancerProgress]

@andrewpannu Fantastic analysis would love to see the high res. If you’re amenable, I might use it an upcoming talk in a couple weeks and of course I would cite you.

[Axios @axios]

NEW: Elon Musk, Peter Thiel and Steve Bannon are all named in Epstein docs released today by Democrats

https://t.co/BeX2fxmxmc

[Cancer Progress @CancerProgress]

Good news, but…If we don’t guns and rears early innovation sufficiently we won’t have these later stage readouts. And I still don’t buy the “purge” as a rationale cleansing of only unworthy companies, programs and platforms.

[Daphne Zohar @daphnezohar]

Bullish biotech report from Stifel. Rates, risk on, M&A picking up & pharma desperate to fill patent cliff w/ $1.2 trillion of firepower, “biotech cleanse” (eg more quality names with late stage data after multi-year purge), specialist funds recovered, generalists coming back $XBI $IBB

[Cancer Progress @CancerProgress]

https://t.co/0MlHj5jV4U

[Cancer Progress @CancerProgress]

Thank you, Dr. Hotez, for you ongoing courage and insights in the face of a seemingly insurmountable onslaught of inanity.

[Prof Peter Hotez MD PhD DSc(hon) @PeterHotez]

Anti-science kills: From Soviet embrace of pseudoscience to accelerated attacks on US biomedicine | my 2021 article in ⁦@PLOS⁩ ⁦@PLOSBiology⁩ https://t.co/3bNJW7wniJ

[Jacob Plieth @JacobPlieth]

How $BNTX turned $800m into $1.5bn, via @ApexOnco -> https://t.co/5BVk9OWMYr Who will be next? #ASCO25 $BMY $PFE $SMMT $TIL

[Jacob Plieth @JacobPlieth]

Here's Huabo's sotiburafusp alfa (HB0025), a PD-L1 x VEGF trap fusion protein.
84% ORR in endometrial cancer, and it might cost you less than $1.25bn #ASCO25 $BNTX $SMMT $PFE

[Brad Loncar @bradloncar]

PD(L)1xVEGF

𝐇𝐨𝐰 𝐢𝐭 𝐬𝐭𝐚𝐫𝐭𝐞𝐝: It's a fraud.

𝐇𝐨𝐰 𝐢𝐭'𝐬 𝐠𝐨𝐢𝐧𝐠: You can't afford not to own one.

The first class of medicine where every asset has originated in China.